The Digital Pathology Market was worth US$ 6.19 Billion in the year 2022 and is expected to reach US$ 22.87 Billion by the year 2032 at a notable CAGR of 13.5% between 2022 and 2032.
Future Market Insights has walked through these facets with future prospects in its latest market study entitled ‘Digital Pathology Market’. It has its determined team of analysts and consultants to look through its primary, secondary, and tertiary modes of research through 360-degree approach.
Request a Report Sample and Gain a Competitive Advantage@ https://www.futuremarketinsights.com/reports/sample/rep-gb-124
The current scenario is such that AI is being increasingly incorporated in healthcare. As such, greater focus is being laid on enhancement of quality of patient care by using AI in several phases of the healthcare services like pathological diagnosis. There are AI-based tools called clinical decision support systems that are helping in improving medical care and helping hospitals in having the workflow streamlined. Aiosyn, in March 2023, came up with AiosynQC – an AI-enabled algorithm capable of autoscan. It’s the first of its kind to aid Digital Pathology labs in diagnostics, research, and pharmaceuticals enhance the QC (Quality Control) processes.
“Telepathology is expected to be the cornerstone of Digital Pathology market in the forecast period”, says an analyst from Future Market Insights.
Key Takeaways from Digital Pathology Market
- North America holds more than 40% of the market share. This could be credited to growing initiatives by the government of the US regarding development of the technologically advanced pathologies with continuous adoption of the digital imaging. On these grounds, PathAI, in March 2023, did launch AISight. It comes across as one of the Digital Pathology platforms across the US in reference laboratories, health systems, independent pathology organizations, and medical centers for participating in Early Access Program. Academic research also asks for Digital Pathology.
- Europe holds the second-largest market share with Germany leading from the front. This could be credited to guidelines that German Association of Pathologists has laid down stern guidelines to be followed for such procedures in healthcare sector.
- The Asia-Pacific is likely to witness the quickest CAGR in the Digital Pathology market going forward. This could be credited to speedy penetration of digital imaging in the developing economies. Along these lines, Qritive, in March 2023, collaborated with Corista to integrate AI using DP3 (DICOM-compliant pathology software).
Contact Us for a Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-124
Competitive Analysis
- Pramana, in October 2022, did showcase its DPaaS (Digital Pathology as a Service) solution and tabled Digital Pathology 2.0. The company also presented two posters on power of its WSI (whole slide imaging) process. This DPaaS does offer pathology laboratories a cost-effective, seamless, and higher quality digital image of the pathology slides by doing away with operation-related hassles.
- Proscia, in October 2022, put forth its new-fangled Digital Pathology platform meant to transform diagnostics.
- Concentriq Dx floored its subsequent version marked especially for IVDR compliance. This would basically facilitate pathology to keep microscopes at bay.
- Paige, in September 2022, collaborated with OptraSCAN to streamline adopting Digital Pathology technology in the EU and US. The basic purpose was to improvise on workflows of pathology and oncology by curtailing barriers to digitization of glass pathology slides.
- Visiopharm, in September 2021, entered into collaboration with Agilent technologies, Inc. for co-marketing the former’s portfolio of AI-driven, CE-IVD marked Precision pathology software and the latter’s automated pathology staining solutions.
- Leica Biosystems, in April 2021, entered into partnership with Paige AI, Inc. for using the latter’s AI-enabled research software to detect humor to quantify the former’s Digital Pathology platform in Europe and North America.
Key Players
- Danaher Corporation
- F. Hoffmann-La Roche AG
- Huron Technologies International Inc.
- Koninklijke Philips N.V.
- Olympus Corporation
- Hamamatsu Photonics K.K.
- Carl Zeiss AG
- Others
Visit For Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-124
Key Segments Profiled in the Global Digital Pathology Market
Digital Pathology by Product Type:
- Digital Pathology Equipment
- Whole Slide Scanners
- Brightfield Slide Scanners
- Fluorescence Slide Scanners
- Combination Slide Scanners
- Clinical Microscope
- Tissue Microarrays
- Whole Slide Scanners
- Digital Pathology Software
- Image Viewing and Analysis Software
- On-premise
- Cloud-based
- Image Viewing and Analysis Software
- Digital Pathology Information Systems
- On-premise
- Cloud-based
- Digital Pathology Services
- Installation and Integration Services
- Consulting Services
- Maintenance and Validation Services
Digital Pathology by Application:
- Clinical Pathology
- Molecular Diagnostics
- Basic & Applied Research
- Drug Development
- Others
Digital Pathology by End User:
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Forensic Laboratories
- Research Institutes
- Contract Research Organizations (CROs)
- Clinics
About Future Market Insights, Inc.
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs
